BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $219,000 | -29.1% | 4,141 | -24.1% | 0.00% | 0.0% |
| Q1 2020 | $309,000 | -17.8% | 5,456 | -17.4% | 0.00% | 0.0% |
| Q4 2019 | $376,000 | +5.3% | 6,603 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $357,000 | -18.5% | 6,670 | -9.1% | 0.00% | -50.0% |
| Q2 2019 | $438,000 | -19.6% | 7,339 | -16.0% | 0.00% | 0.0% |
| Q1 2019 | $545,000 | +4.6% | 8,739 | +1.6% | 0.00% | 0.0% |
| Q4 2018 | $521,000 | -0.4% | 8,605 | -3.9% | 0.00% | 0.0% |
| Q3 2018 | $523,000 | +26.3% | 8,950 | -3.0% | 0.00% | 0.0% |
| Q2 2018 | $414,000 | -10.0% | 9,230 | -11.0% | 0.00% | 0.0% |
| Q1 2018 | $460,000 | -8.4% | 10,365 | -10.6% | 0.00% | 0.0% |
| Q4 2017 | $502,000 | -6.0% | 11,595 | +1.0% | 0.00% | 0.0% |
| Q3 2017 | $534,000 | – | 11,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |